vs

Side-by-side financial comparison of Astera Labs, Inc. (ALAB) and Concentra Group Holdings Parent, Inc. (CON). Click either name above to swap in a different company.

Concentra Group Holdings Parent, Inc. is the larger business by last-quarter revenue ($539.1M vs $270.6M, roughly 2.0× Astera Labs, Inc.). Astera Labs, Inc. runs the higher net margin — 16.6% vs 6.4%, a 10.2% gap on every dollar of revenue. Concentra Group Holdings Parent, Inc. produced more free cash flow last quarter ($98.5M vs $76.6M).

Astera Labs, Inc. is an American fabless semiconductor manufacturer and artificial intelligence company. The company specializes in designing high-speed connectivity solutions for data centers and AI infrastructure. The company has been listed on the Nasdaq since March 2024.

Concentra Inc., is a national health care establishment centered around occupational health. It was founded in 1979 in Amarillo, Texas, and the headquarters of the corporation is in Addison, Texas. It runs 627 occupational health centers and 410 onsite health clinics at employer worksites across 47 states. According to the Bureau of Labor Statistics, Concentra treats one out of every seven occupational injuries in the United States. It is currently a publicly traded company with over 80% of t...

ALAB vs CON — Head-to-Head

Bigger by revenue
CON
CON
2.0× larger
CON
$539.1M
$270.6M
ALAB
Higher net margin
ALAB
ALAB
10.2% more per $
ALAB
16.6%
6.4%
CON
More free cash flow
CON
CON
$21.9M more FCF
CON
$98.5M
$76.6M
ALAB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ALAB
ALAB
CON
CON
Revenue
$270.6M
$539.1M
Net Profit
$45.0M
$34.7M
Gross Margin
75.6%
Operating Margin
24.7%
12.9%
Net Margin
16.6%
6.4%
Revenue YoY
91.8%
Net Profit YoY
82.0%
EPS (diluted)
$0.25
$0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALAB
ALAB
CON
CON
Q4 25
$270.6M
$539.1M
Q3 25
$230.6M
$572.8M
Q2 25
$191.9M
$550.8M
Q1 25
$159.4M
$500.8M
Q4 24
$141.1M
Q3 24
$113.1M
$489.6M
Q2 24
$76.8M
$477.9M
Q1 24
$65.3M
Net Profit
ALAB
ALAB
CON
CON
Q4 25
$45.0M
$34.7M
Q3 25
$91.1M
$48.3M
Q2 25
$51.2M
$44.6M
Q1 25
$31.8M
$38.9M
Q4 24
$24.7M
Q3 24
$-7.6M
$44.3M
Q2 24
$-7.5M
$51.7M
Q1 24
$-93.0M
Gross Margin
ALAB
ALAB
CON
CON
Q4 25
75.6%
Q3 25
76.2%
Q2 25
75.8%
Q1 25
74.9%
Q4 24
74.0%
Q3 24
77.7%
Q2 24
77.9%
Q1 24
77.4%
Operating Margin
ALAB
ALAB
CON
CON
Q4 25
24.7%
12.9%
Q3 25
24.0%
16.5%
Q2 25
20.7%
16.3%
Q1 25
7.1%
16.0%
Q4 24
0.1%
Q3 24
-7.9%
17.6%
Q2 24
-31.7%
17.6%
Q1 24
-127.1%
Net Margin
ALAB
ALAB
CON
CON
Q4 25
16.6%
6.4%
Q3 25
39.5%
8.4%
Q2 25
26.7%
8.1%
Q1 25
20.0%
7.8%
Q4 24
17.5%
Q3 24
-6.7%
9.1%
Q2 24
-9.8%
10.8%
Q1 24
-142.5%
EPS (diluted)
ALAB
ALAB
CON
CON
Q4 25
$0.25
$0.27
Q3 25
$0.50
$0.38
Q2 25
$0.29
$0.35
Q1 25
$0.18
$0.30
Q4 24
$1.23
Q3 24
$-0.05
$0.37
Q2 24
$-0.05
$0.50
Q1 24
$-1.77

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALAB
ALAB
CON
CON
Cash + ST InvestmentsLiquidity on hand
$167.6M
$79.9M
Total DebtLower is stronger
$1.6B
Stockholders' EquityBook value
$1.4B
$393.3M
Total Assets
$1.5B
$2.9B
Debt / EquityLower = less leverage
3.98×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALAB
ALAB
CON
CON
Q4 25
$167.6M
$79.9M
Q3 25
$140.4M
$49.9M
Q2 25
$162.3M
$73.9M
Q1 25
$86.4M
$52.1M
Q4 24
$79.6M
Q3 24
$126.1M
$136.8M
Q2 24
$421.1M
$50.7M
Q1 24
$696.1M
Total Debt
ALAB
ALAB
CON
CON
Q4 25
$1.6B
Q3 25
$1.6B
Q2 25
$1.7B
Q1 25
$1.6B
Q4 24
Q3 24
$1.5B
Q2 24
$3.0M
Q1 24
Stockholders' Equity
ALAB
ALAB
CON
CON
Q4 25
$1.4B
$393.3M
Q3 25
$1.3B
$385.5M
Q2 25
$1.1B
$342.6M
Q1 25
$1.0B
$307.1M
Q4 24
$964.8M
Q3 24
$889.6M
$277.8M
Q2 24
$845.3M
$1.2B
Q1 24
$808.8M
Total Assets
ALAB
ALAB
CON
CON
Q4 25
$1.5B
$2.9B
Q3 25
$1.4B
$2.8B
Q2 25
$1.3B
$2.8B
Q1 25
$1.1B
$2.7B
Q4 24
$1.1B
Q3 24
$983.1M
$2.5B
Q2 24
$915.5M
$2.4B
Q1 24
$864.9M
Debt / Equity
ALAB
ALAB
CON
CON
Q4 25
3.98×
Q3 25
4.15×
Q2 25
4.82×
Q1 25
5.27×
Q4 24
Q3 24
5.30×
Q2 24
0.00×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALAB
ALAB
CON
CON
Operating Cash FlowLast quarter
$95.3M
$118.7M
Free Cash FlowOCF − Capex
$76.6M
$98.5M
FCF MarginFCF / Revenue
28.3%
18.3%
Capex IntensityCapex / Revenue
6.9%
3.7%
Cash ConversionOCF / Net Profit
2.12×
3.42×
TTM Free Cash FlowTrailing 4 quarters
$281.8M
$197.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALAB
ALAB
CON
CON
Q4 25
$95.3M
$118.7M
Q3 25
$78.2M
$60.6M
Q2 25
$135.4M
$88.4M
Q1 25
$10.5M
$11.7M
Q4 24
$39.7M
Q3 24
$63.5M
$65.9M
Q2 24
$29.8M
Q1 24
$3.7M
Free Cash Flow
ALAB
ALAB
CON
CON
Q4 25
$76.6M
$98.5M
Q3 25
$65.9M
$39.4M
Q2 25
$133.3M
$63.2M
Q1 25
$6.0M
$-4.0M
Q4 24
$24.3M
Q3 24
$46.8M
$50.8M
Q2 24
$28.5M
Q1 24
$228.0K
FCF Margin
ALAB
ALAB
CON
CON
Q4 25
28.3%
18.3%
Q3 25
28.6%
6.9%
Q2 25
69.5%
11.5%
Q1 25
3.7%
-0.8%
Q4 24
17.2%
Q3 24
41.4%
10.4%
Q2 24
37.1%
Q1 24
0.3%
Capex Intensity
ALAB
ALAB
CON
CON
Q4 25
6.9%
3.7%
Q3 25
5.3%
3.7%
Q2 25
1.1%
4.6%
Q1 25
2.8%
3.1%
Q4 24
10.9%
Q3 24
14.8%
3.1%
Q2 24
1.7%
Q1 24
5.2%
Cash Conversion
ALAB
ALAB
CON
CON
Q4 25
2.12×
3.42×
Q3 25
0.86×
1.26×
Q2 25
2.64×
1.98×
Q1 25
0.33×
0.30×
Q4 24
1.61×
Q3 24
1.49×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALAB
ALAB

Segment breakdown not available.

CON
CON

Occupational Health Center Workers Compensation$328.5M61%
Occupational Health Center Employer Services$151.9M28%
Onsite Health Clinics$36.2M7%
Other Businesses$12.3M2%
Occupational Health Center Consumer Health$8.1M2%
Occupational Health Center Other$2.1M0%

Related Comparisons